medical.allograftBackground: Meniscal allograft transplantation (MAT) is a treatment option for knee pain in young patients with meniscal deficiency?in the setting of intact articular surfaces, ligamentous stability, and normal alignment. It is being performed with increasing?frequency, and the need for reoperations is not uncommon. A mean survival rate of allografts and indications for reoperations?would be helpful information when counseling patients regarding the procedure.

Purpose/Hypothesis: The purpose of this study was to quantify survival for MAT and report findings at reoperation. The hypothesis?was that the reoperation rate would be frequent and that the most common secondary surgery would be arthroscopic?debridement.

Study Design: Case series; Level of evidence, 4.?Methods: A retrospective review of a prospectively collected database of patients who underwent MAT from 2003 to 2011 was?conducted; all surgeries were performed by a single surgeon. The reoperation rate, timing of reoperation, procedure performed at?reoperation, and findings at surgery, including the status of the meniscal and articular cartilage, were reviewed. Survival was?defined as a lack of revision MAT or knee arthroplasty. Descriptive statistics, log-rank testing, cross-tabulation, and x2 testing?were analyzed, with an a value of .05 set as significant.

Results: Of 200 patients who underwent MAT during the study period, 172 patients (86%; mean age, 34.3 6 10.3 years) were?evaluated at a mean of 59 months (range, 24-118 months) with a minimum 2-year follow-up. Forty-one percent of MATs were?isolated, while 60% were performed with concomitant procedures. Sixty-four patients (32%) returned to the operating room after?their index procedure. Arthroscopic debridement was performed in 59% (38/64) of these patients. The mean time to subsequent?surgery was 21 months (range, 2-107 months), with 73% occurring within 2 years. Eight of 172 patients (4.7%) went on to require?revision MAT or total knee replacement. Patients requiring secondary surgery within 2 years had an odds ratio of 8.4 (95% CI, 1.6-43.4) for future arthroplasty or MAT revision (P = .007).

Conclusion: In this series, there was a 32% reoperation rate for MAT, with simple arthroscopic debridement being the most common?surgical treatment (59%), and a 95% allograft survival rate at a mean of 5 years. Those requiring additional surgery still?benefited, having an 88% allograft survival rate, but were at an increased risk of failure. Patients requiring secondary surgery?within 2 years had an odds ratio of 8.4 for future arthroplasty or MAT revision. [read complete artlcle]

Click here for full podcast playlist.